Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000175662 | SCV000227195 | benign | not specified | 2015-06-03 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000443976 | SCV000511193 | likely benign | not provided | 2017-02-16 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Gene |
RCV000443976 | SCV000532980 | benign | not provided | 2019-09-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000443976 | SCV002453996 | benign | not provided | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002243850 | SCV002514343 | benign | Brittle cornea syndrome 1 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002415753 | SCV002720102 | benign | Cardiovascular phenotype | 2020-10-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000443976 | SCV003917852 | benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | ZNF469: BP4, BS1, BS2 |
Breakthrough Genomics, |
RCV000443976 | SCV005217592 | likely benign | not provided | criteria provided, single submitter | not provided |